Fast growing angiosarcoma of the right atrium after radiofrequency catheter ablation: a missed diagnosis or misdiagnosis case report
- PMID: 31906980
- PMCID: PMC6945586
- DOI: 10.1186/s12885-019-6450-2
Fast growing angiosarcoma of the right atrium after radiofrequency catheter ablation: a missed diagnosis or misdiagnosis case report
Abstract
Background: Primary angiosarcomas of the right atrium are extremely rare, often resulted in missed diagnosis or misdiagnosis with routine examination tools. These malignant cardiac tumors are highly aggressive with generally poor prognosis. Surgical excision is the mainstay of treatment as it is essentially not responsive to current regimens of chemoradiotherapy.
Case presentation: Herein, we describe a patient who initially presented with paroxysmal atrial fibrillation and was subsequently treated with radiofrequency catheter ablation (RFCA). Prior to RFCA, an initial transesophageal echocardiography revealed a local thickening of the intratrial septum. Three months later, she was hospitalized with progressive dyspnea and massive pericardial effusion. A large immobile, non-pedunculated mass, occupying almost half of the right atrium was detected by transthoracic and transesophageal echocardiogram. Multimodality cardiac imaging was useful in further characterizing this mass, which was ultimately diagnosed as an angiosarcoma based upon biopsy results. The growth rate was extremely rapid following RFCA, and patient underwent surgical excision. After discharge, the angiosarcoma recurred and patient survived for 7 months from the first episode of tamponade.
Conclusions: Primary cardiac angiosarcoma of the right atrium can easily be mistaken for structural anomalies in its early stages, losing the opportunity for initiating earlier treatments to improve potential patient outcomes. The correct diagnosis of this rare case relied on the comprehensive utilization of multimodal imaging techniques including biopsy.
Keywords: Cardiac imaging; Cardiac tumor.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
[Hemorrhagic nonspecific pericardial effusion as an initial symptom of angiosarcoma of the right heart].Z Kardiol. 2004 Oct;93(10):807-12. doi: 10.1007/s00392-004-0124-y. Z Kardiol. 2004. PMID: 15492896 German.
-
[Malignant angiosarcoma of the right atrium in pregnancy. Diagnostic and therapeutic problems].Herz. 1994 Jun;19(3):166-70. Herz. 1994. PMID: 7927128 German.
-
Left atrial angiosarcoma: an unusual presentation and location.J Heart Valve Dis. 2011 Mar;20(2):229-31. J Heart Valve Dis. 2011. PMID: 21560827 Review.
-
A large angiosarcoma of the right atrium: anaesthetic management.Hellenic J Cardiol. 2011 May-Jun;52(3):273-7. Hellenic J Cardiol. 2011. PMID: 21642079
-
Right atrial epithelioid angiosarcoma with multiple pulmonary metastasis confirmed by multimodality imaging-guided pulmonary biopsy: A case report and literature review.Medicine (Baltimore). 2018 Jul;97(30):e11588. doi: 10.1097/MD.0000000000011588. Medicine (Baltimore). 2018. PMID: 30045289 Free PMC article. Review.
Cited by
-
Primary cardiac tumor: a case report of right atrial angiosarcoma and review of the literature.Front Oncol. 2023 May 26;13:1164153. doi: 10.3389/fonc.2023.1164153. eCollection 2023. Front Oncol. 2023. PMID: 37305576 Free PMC article.
-
Cardiac angiosarcoma in acute pericardial tamponade with hemoptysis: A case report.J Int Med Res. 2025 May;53(5):3000605251339142. doi: 10.1177/03000605251339142. Epub 2025 May 29. J Int Med Res. 2025. PMID: 40439058 Free PMC article.
-
Primary cardiac angiosarcoma masquerading as intracardiac thrombus.BMJ Case Rep. 2020 Dec 9;13(12):e236806. doi: 10.1136/bcr-2020-236806. BMJ Case Rep. 2020. PMID: 33298483 Free PMC article.
-
Primary Cardiac Epithelioid Angiosarcoma with Sustained Remission following Surgical Resection: A Case Report.Case Rep Oncol. 2023 Sep 12;16(1):878-885. doi: 10.1159/000530113. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37900857 Free PMC article.
-
Recent updates on novel therapeutic targets of cardiovascular diseases.Mol Cell Biochem. 2021 Jan;476(1):145-155. doi: 10.1007/s11010-020-03891-8. Epub 2020 Aug 26. Mol Cell Biochem. 2021. PMID: 32845435 Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources